We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Off target

4 February 2016 By Neil Unmack

The UK pharma group may miss the earnings targets Chief Executive Pascal Soriot must meet to get his bonus. But it may adjust Soriot’s goal to reduce the effect of “dilutive” acquisitions. There’s logic to that, but Astra’s accounting gymnastics undermine its rigour on pay.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)